• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用药代动力学/药效学建模与模拟预测万古霉素的抗生素效应:密集采样与稀疏采样

Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling.

作者信息

Kim Yong Kyun, Lee Jae Ha, Jang Hang-Jea, Zang Dae Young, Lee Dong-Hwan

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14066, Korea.

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Korea.

出版信息

Antibiotics (Basel). 2022 May 31;11(6):743. doi: 10.3390/antibiotics11060743.

DOI:10.3390/antibiotics11060743
PMID:35740150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9220236/
Abstract

This study aimed to investigate the effect of a structural pharmacokinetic (PK) model with fewer compartments developed following sparse sampling on the PK parameter estimation and the probability of target attainment (PTA) prediction of vancomycin. Two- and three-compartment PK models of vancomycin were used for the virtual concentration-time profile simulation. Datasets with reduced blood sampling times were generated to support a model with a lesser number of compartments. Monte Carlo simulation was conducted to evaluate the PTA. For the two-compartment PK profile, the total clearance (CL) of the reduced one-compartment model showed a relative bias (RBias) and relative root mean square error (RRMSE) over 90%. For the three-compartment PK profile, the CL of the reduced one-compartment model represented the largest RBias and RRMSE, while the steady-state volume of distribution of the reduced two-compartment model represented the largest absolute RBias and RRMSE. A lesser number of compartments corresponded to a lower predicted area under the concentration-time curve of vancomycin. The estimated PK parameters and predicted PK/PD index from models built with sparse sampling designs that cannot support the PK profile can be significantly inaccurate and unprecise. This might lead to the misprediction of the PTA and selection of improper dosage regimens when clinicians prescribe antibiotics.

摘要

本研究旨在探讨基于稀疏采样构建的较少房室结构药代动力学(PK)模型对万古霉素PK参数估计及达标概率(PTA)预测的影响。采用万古霉素的二房室和三房室PK模型进行虚拟浓度-时间曲线模拟。生成减少血样采集时间的数据集以支持较少房室数的模型。进行蒙特卡洛模拟以评估PTA。对于二房室PK曲线,简化的一房室模型的总清除率(CL)显示相对偏差(RBias)和相对均方根误差(RRMSE)超过90%。对于三房室PK曲线,简化的一房室模型的CL表现出最大的RBias和RRMSE,而简化的二房室模型的稳态分布容积表现出最大的绝对RBias和RRMSE。较少的房室数对应较低的万古霉素浓度-时间曲线下预测面积。基于无法支持PK曲线的稀疏采样设计构建的模型所估计的PK参数和预测的PK/PD指数可能会显著不准确和不精确。这可能导致临床医生在开具抗生素处方时对PTA的错误预测以及选择不恰当的给药方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/0d61c2a5bee2/antibiotics-11-00743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/96b5339a9257/antibiotics-11-00743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/f08583f7c75e/antibiotics-11-00743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/bb9b59919854/antibiotics-11-00743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/5cb630dca6d2/antibiotics-11-00743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/0d61c2a5bee2/antibiotics-11-00743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/96b5339a9257/antibiotics-11-00743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/f08583f7c75e/antibiotics-11-00743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/bb9b59919854/antibiotics-11-00743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/5cb630dca6d2/antibiotics-11-00743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93c/9220236/0d61c2a5bee2/antibiotics-11-00743-g005.jpg

相似文献

1
Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling.使用药代动力学/药效学建模与模拟预测万古霉素的抗生素效应:密集采样与稀疏采样
Antibiotics (Basel). 2022 May 31;11(6):743. doi: 10.3390/antibiotics11060743.
2
Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.两种使用首剂后估算曲线下面积优化万古霉素给药剂量的创新方法:利用群体药代动力学模型结合蒙特卡洛模拟生成的数据进行验证,并与一级药代动力学方程方法进行比较。
Pharmaceutics. 2022 May 7;14(5):1004. doi: 10.3390/pharmaceutics14051004.
3
Effect of pharmacokinetic model misspecification on antibiotic probability of target attainment predicted by Monte Carlo simulation
.药代动力学模型设定错误对蒙特卡罗模拟预测的抗生素达标概率的影响
Int J Clin Pharmacol Ther. 2019 Jul;57(7):362-374. doi: 10.5414/CP203446.
4
Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.体外膜肺氧合成人患者万古霉素群体药代动力学和药效学目标达成的前瞻性队列研究。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02408-20.
5
Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing.模型引导精准给药中采样和输注时间记录不准确的影响
Front Pharmacol. 2020 Mar 3;11:172. doi: 10.3389/fphar.2020.00172. eCollection 2020.
6
Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.心脏直视手术万古霉素群体药动学模型:基于模型的标准给药方案评价。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00088-18. Print 2018 Jul.
7
Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.万古霉素在重症监护病房患者中的药代动力学/药效学分析。
Intensive Care Med. 2007 Feb;33(2):279-85. doi: 10.1007/s00134-006-0470-5. Epub 2006 Dec 13.
8
Vancomycin dose optimisation comparing a pharmacokinetic/pharmacodynamic model versus the pharmacokinetic model.比较药代动力学/药效学模型与药代动力学模型的万古霉素剂量优化
Eur J Hosp Pharm. 2019 Jan;26(1):16-22. doi: 10.1136/ejhpharm-2017-001222. Epub 2017 Aug 28.
9
Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.中国患者中新型恶唑烷酮类抗菌药物康替唑胺的群体药代动力学研究。
Clin Ther. 2020 May;42(5):818-829. doi: 10.1016/j.clinthera.2020.03.020. Epub 2020 May 7.
10
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support.万古霉素和美罗培南在小儿体外膜肺氧合支持中的群体药代动力学
Front Pharmacol. 2021 Aug 13;12:709332. doi: 10.3389/fphar.2021.709332. eCollection 2021.

引用本文的文献

1
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.基于模型的利奈唑胺和万古霉素对耐甲氧西林金黄色葡萄球菌的药代动力学-药效学关系翻译:从体外时间杀菌实验到小鼠肺炎模型
J Antimicrob Chemother. 2025 Jul 1;80(7):1860-1868. doi: 10.1093/jac/dkaf140.
2
Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?当对外评估群体药代动力学模型时,样本量、采样策略或低于定量下限浓度的处理是否重要?
Eur J Drug Metab Pharmacokinet. 2024 Jul;49(4):419-436. doi: 10.1007/s13318-024-00897-1. Epub 2024 May 5.
3

本文引用的文献

1
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.个体化抗生素药代动力学和药效学在危重症患者中的应用。
Anaesth Crit Care Pain Med. 2021 Dec;40(6):100970. doi: 10.1016/j.accpm.2021.100970. Epub 2021 Oct 30.
2
Precision medicine in 2030-seven ways to transform healthcare.2030 年的精准医学——改变医疗的七种方式。
Cell. 2021 Mar 18;184(6):1415-1419. doi: 10.1016/j.cell.2021.01.015.
3
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.从治疗药物监测到抗生素模型指导下的精准给药。
Beyond One-Size-Fits-All: Tailoring Teicoplanin Regimens for Normal Renal Function Patients Using Population Pharmacokinetics and Monte Carlo Simulation.超越一刀切:利用群体药代动力学和蒙特卡洛模拟为肾功能正常患者量身定制替考拉宁治疗方案。
Pharmaceutics. 2024 Apr 5;16(4):499. doi: 10.3390/pharmaceutics16040499.
4
Concentrations of Co-Administered Meropenem and Vancomycin in Spinal Tissues Relevant for the Treatment of Pyogenic Spondylodiscitis-An Experimental Microdialysis Study.与化脓性脊椎椎间盘炎治疗相关的脊髓组织中联合使用美罗培南和万古霉素的浓度——一项实验性微透析研究
Antibiotics (Basel). 2023 May 14;12(5):907. doi: 10.3390/antibiotics12050907.
5
Editorial: Special Issue on Pharmacokinetic/Pharmacodynamic Models of Antibiotics.社论:抗生素药代动力学/药效学模型特刊
Antibiotics (Basel). 2022 Nov 3;11(11):1540. doi: 10.3390/antibiotics11111540.
Clin Pharmacol Ther. 2021 Apr;109(4):928-941. doi: 10.1002/cpt.2202. Epub 2021 Mar 16.
4
Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.体外膜肺氧合成人患者万古霉素群体药代动力学和药效学目标达成的前瞻性队列研究。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02408-20.
5
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations.数字健康时代模型驱动的精准给药展望:挑战、机遇与建议
Clin Pharmacol Ther. 2021 Jan;109(1):29-36. doi: 10.1002/cpt.2049. Epub 2020 Oct 17.
6
Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?采样时间对抗生素群体药代动力学分析的影响:为何在第四次给药后采集血样?
Pharmaceuticals (Basel). 2020 Sep 16;13(9):249. doi: 10.3390/ph13090249.
7
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?模型指导下的精准给药软件工具:它们在多大程度上满足了需求?
Front Pharmacol. 2020 May 7;11:620. doi: 10.3389/fphar.2020.00620. eCollection 2020.
8
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测:美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
9
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults.万古霉素群体药代动力学分析的最新进展,第一部分:成人篇。
Clin Pharmacokinet. 2020 Jun;59(6):671-698. doi: 10.1007/s40262-020-00866-2.
10
Effect of pharmacokinetic model misspecification on antibiotic probability of target attainment predicted by Monte Carlo simulation
.药代动力学模型设定错误对蒙特卡罗模拟预测的抗生素达标概率的影响
Int J Clin Pharmacol Ther. 2019 Jul;57(7):362-374. doi: 10.5414/CP203446.